Clinical trial
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate
NCT00429338 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00429338 |
|---|---|
| Title | 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate |
| Official title | Feasibility Study of 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | AIR-MRSI, PFC-MRSI |
| Enrollment | 8 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2013 |
| Completion | Oct 1, 2013 |
| First posted | Jan 31, 2007 |
| Last update posted | Jan 9, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: